Caliper Life Sciences to Acquire NovaScreen Biosciences for Up to $30M in Stock and Cash | GenomeWeb

NEW YORK, Sept. 8 (GenomeWeb News) - Caliper Life Sciences plans to acquire NovaScreen Biosciences, a screening, profiling, and assay development-services company for up to $30 million in stock and cash, Caliper said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.